Shearman & Sterling represented Goldman, Sachs & Co., Deutsche Bank Securities and Morgan Stanley as underwriters in connection with a secondary public offering of 18,991,827 shares of common stock of Catalent, Inc. by certain of its stockholders. Catalent, Inc. is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.